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An in situ combinatorial methodology to
synthesize and screen chemical probes†
Antonie J. van der Zouwen, ‡ Jonas Lohse, ‡ Lianne H. E. Wieske,
Katharina F. Hohmann, Ramon van der Vlag and Martin D. Witte *
Chemical probes that label proteins of interest in the context of
complex biological samples are useful research tools. The reactive
group that forms the covalent bond with the target protein has a
large eﬀect on the selectivity and selecting the appropriate group
determines the success of a probe. We here report the development
of a combinatorial methodology based on imine chemistry that
enables straightforward in situ synthesis and screening of diﬀerent
reactive groups and thereby simplifies identification of probe leads.
Using our methodology, we found chemical probes targeting BirA
and chloramphenicol acetyl transferase, two proteins associated
with antibacterial activity and resistance.
Chemical probes that covalently introduce a bioorthogonal
handle or reporter group onto a protein of interest (POI) have
become fundamental research tools.1 They enable functional
studies in biologically relevant settings and have been applied
to identify the targets of biologically active compounds.2 To
prepare chemical probes for a POI, often ligands or inhibitors
are functionalized with a reactive group that covalently modifies
an amino acid within the proximity of the binding pocket.3
A variety of reactive groups has been employed for this purpose
and selecting the appropriate ligand-reactive group combination
is key to the success of the probe.4 Not only may the reactive
group alter the biological activity, but it also determines to
a large extent if proteins get labeled at all.5 Probes will only
label their target eﬃciently if the reactive group is positioned
correctly.4k Molecular modeling can address this issue in part,
but often knowledge of the targets is lacking and a major
challenge therefore remains in finding the optimal ligand-
reactive group combination. As a consequence, sets of probes
are synthesized that vary in the position and the chemotype
of the reactive group.4e,k The synthesis, purification and
(bio)chemical analysis of these probes are time consuming and
form a serious bottleneck in probe development. Combinatorial
approaches and fragment-based screening have been explored to
speed-up synthesis of chemical probes.6 However, in the former
approach the individual probes still need to be purified and
analyzed, while the latter is more suitable for the serendipitous
identification of leads. The field of drug discovery has tackled
similar challenges by developing combinatorial chemistries that
combine preparing and screening of compound libraries in one
simple operation.7 Imine chemistry has proven to be suitable for
this purpose, since it allows straightforward linking of fragments
by mixing reaction partners, with only water as the by-product.
Inspired by these in situ approaches and encouraged by earlier
reports of imine-containing probes,8 we set out to develop a similar
combinatorial strategy for the synthesis and screening of chemical
probes. We here report the first proof-of-concept study of how
acylhydrazone and oxime formation can be used to tether ligands
and inhibitors to reactive groups in situ (Fig. 1). With this method,
we functionalized several a-nucleophiles with commonly used
reactive groups. The in situ generated probes label their targets
bovine carbonic anhydrase II (CA-II), streptavidin (Strp), avidin (AVI)
and BirA. The selectivity and specificity of a particular ligand-reactive
group combination is easily assessed by gel-based screening of
the reaction mixtures. We believe that our modular approach can
dramatically simplify the identification of new leads for probes.
Fig. 1 Schematic representation of the combinatorial probe synthesis
approach. a-Nucleophile ligands (L) that bind to the protein of interest
(POI) are mixed with carbonyl-containing reactive groups (R). The resulting
probes modify the POI with a TAG (bioorthogonal handle or fluorophore).
By comparing the TAG signal of the targeted probe with a non-targeted
control (red cross), the eﬃciency of the probe can be determined.
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To study if combinatorial chemistry can be employed to screen
ligand-reactive group combinations, we decided to synthesize
aldehyde and ketone derivatives of acyl imidazoles,4a diazotransfer
reagents,4b Michael acceptors,4c alkylating agents,4d sulfonyl
fluorides,4e–g sulfonate esters,4h Woodward’s reagent K4i and
photocrosslinkers4j–l (Fig. 2). These reactive groups are commonly
used in chemical probes and target a broad panel of amino acids.
The required aldehydes R1–R9 were readily prepared from com-
mercially available building blocks in no more than four steps.
Considering that R1–R5 could decompose in the presence of
a-nucleophiles, we first evaluated if in situ synthesis of the probes
was feasible. 1H-NMR (Fig. S1, ESI†) and UPLC-MS (Fig. S2, ESI†)
experiments with acethydrazide and methoxyamine revealed that
R1–R3 and R5 can be linked to ligands using imine chemistry.
However, R4 is not suitable, as it readily decomposed, even in the
absence of an a-nucleophile.
Next, we assessed if the in situ formed probes could be used for
protein labeling experiments on a mixture of Strp, CA-II and
ovalbumin (OVA). We selected this model system, because Strp
and CA-II are readily modified with chemical probes that contain
a biotin or benzenesulfonamide targeting group, respectively.4h,9 The
included OVA serves as a first control for protein specificity. By
reacting R1–R4 with an equimolar amount of biotin hydrazide L1,
benzenesulfonamide hydrazide L2 or biotin alkoxyamine L4 over-
night, we prepared a library of probes that target Strp and CA-II. We
also prepared the corresponding non-targeted reagents from acet-
hydrazide L3 as a second control for ligand-independent labeling.
For the proof-of-concept studies, we followed previously reported
labeling protocols.4a,b,kWe added the resulting probes to the protein
mixture in HEPES buffer (pH 7.4) and incubated for 2 hours.
Subsequently, the bioorthogonal handle introduced by the probe
was reacted with a fluorophore reporter group using either copper
catalyzed or strain-promoted alkyne–azide cycloaddition reactions.
The in-gel fluorescence revealed that incubating the protein mixture
with acethydrazide L3-based reagents resulted in minimal labeling
of the proteins (Fig. 2D). The fluorescence intensity for Strp or CA-II
increased considerably when we reacted the aldehydes R1–R3 either
with biotin ligands L1 or L4, or benzenesulfonamide hydrazide
L2, respectively. At the same time the signal for OVA was left
unchanged, which underlines that the target proteins only get
labeled efficiently in the presence of the appropriate ligand.
Comparing the fluorescence intensity of the labeled proteins
indicated that the in situ formed probes containing R1 or R2
label Strp and CA-II with a similar efficiency. The labeling with
R3 is considerably weaker, even when the reaction time was
extended to 6 h. As was expected from the NMR studies, we only
detected a fluorescent signal for R4 when functionalized with
biotin alkoxyamine L4 (Fig. S3, ESI†).
We then performed a similar experiment with R5–R9. These
reagents lack an azide or alkyne handle. To detect the labeled
proteins, we performed a transimination reaction with an excess of
a hydroxylamine fluorophore as has been reported previously.8a
Unfortunately, inefficient exchange of the imine hampered reliable
detection of protein–probe adducts (Fig. S3, ESI†). We therefore
Fig. 2 Development and screening of the imine chemical probes. (A) Carbonyl-containing reactive groups. (B) Biotin and benzenesulfonamide
a-nucleophile ligands. (C) Example of an in situ generated chemical probe. (D) Probes prepared from ligands L1–L4 and reagents R1–R3 modify their
respective targets Strp and CA-II. (E and F) Incorporation of an azido reporter group allows labeling of Strp (E) and avidin (F) using probes prepared with
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evaluated the suitability of R5–R9 for in situ probe formation on
Strp and avidin using azide-functionalized ligands L5 and L6.
These biotin-binding proteins only got labeled efficiently when
R5–R9 were bound to biotin ligand L5. Besides the ligand, also the
reactive group had a large effect on the outcome of the experiment,
which underscores the importance of screening different reactive
groups. Sulfonyl fluoride L5R5 labeled both target proteins
strongly, while aryl fluoride L5R7 modified neither of them
(Fig. 2 and Fig. S3, ESI†). The remaining probes did label Strp,
but labeled avidin only very weakly, despite the structural similarity
between these proteins.
These initial studies demonstrated that in situ probe for-
mation with R1–R3 and R5–R9 is feasible and that incomplete
probe formation does not cause off-target labeling. This was
further confirmed by extending the incubation time (Fig. S4–S6,
ESI†) and by lowering the concentration of the target protein,
while keeping the OVA and probe concentrations constant
(Fig. S7, ESI†). Neither resulted in increased labeling of the
control protein. Even when using multiple probes in a single
sample, we observed selective labeling of the targeted proteins
(Fig. S8, ESI†), suggesting that our method may be suitable to
screen multiple reactive groups in the same sample.
To demonstrate that our modular probe synthesis strategy
can be extended to other proteins, we applied it on BirA from
E. coli. This essential biotin ligase has emerged as a target for
the development of antibacterial agents10 and we recently
showed that a biotin-diazotransfer reagent modifies purified
BirA.11 Unfortunately, this reagent did not label BirA eﬃciently
in more complex samples. To identify new probe leads, we
derivatized biotin ligands L1, L4 and L5 with reactive groups
R1–R3 and R5–R9 and incubated cell lysate of BirA-overexpressing
E. coli with 22.2 mM of the resulting probes for 2 hours. Analysis of
the labeling reaction by fluorescence scanning (for the probes that
contain a bioorthogonal handle) or by western blotting (for the
probes that attach biotin covalently to their targets) showed that
acyl imidazoles L1R2 and L4R2, sulfonyl fluorides L1R5 and L4R5,
alkylating agent L5R7 and photocrosslinker L1R8, L4R8 and L5R8
label BirA rather selectively (Fig. 3 and Fig. S9, ESI†). Interestingly,
biotin sulfonyl fluoride L5R5 labeled, besides BirA, an additional
unidentified protein of approximately 25 kDa. Control probe L6R5
and biotin-based probes L1R5 and L4R5 labeled this off-target
only weakly, suggesting that labeling is ligand-dependent. The
other probes either did not label BirA or showed the same
labeling intensity as the control probes. Again, the reactive
group preferences slightly differ from the other biotin-binding
proteins. Molecular docking of the probes in the X-ray crystal
structure of BirA (PDB ID: 4WF2) provided some insight why
acyl imidazole R2, sulfonyl fluoride R5 and alkylating agent R7
are preferred. Several lysine residues are suitably positioned
near the entrance of the active site and these might react
with these reactive groups (Fig. S10, ESI†). Moreover, the
pentafluoroaryl group of L5R7 is in close proximity of a
methionine residue that might be alkylated. This residue seems
to be out of reach of the other pentafluoroaryl probes.
Next, we analyzed the leads of the screen further by varying
the incubation time and the amount of probe. For most of the
probes, labeling of BirA reached a plateau after 2–4 hours
(Fig. S11, ESI†). The labeling efficiency also demonstrated to
be concentration dependent. At low concentrations, all probes
showed weak labeling of BirA. The signal intensity improved
drastically when we increased the probe concentration.
However, only L1R5, L4R5, L5R7 and L1R8 labeled cleanly at
higher concentrations (Fig. S12, ESI†). Of these probes, we
decided to determine the detection limit of L1R5 and L5R7.
Even though as little as 10 ng of BirA (275 fmol) can be
visualized in E. coli lysate with these probes (Fig. S13, ESI†),
BirA could not be detected in native lysates, presumably due
to the low copy number of BirA per cell (Fig. S14, ESI†).12
Nonetheless, these leads form a good starting point for the
further development of more sensitive probes.
Finally, we focused our attention on the oﬀ-target of L5R5.
Labeling of this protein is concentration- and time-dependent
and could be abolished by heat-denaturing the protein (Fig. 4A,
B and Fig. S15, ESI†). Chemoproteomic analysis of the labeled
protein identified chloramphenicol acetyl transferase 3 (CAT)
as the major hit (Fig. S15 and Table S2, ESI†). The codon-
optimized E. coli strain that we used for the profiling studies
carries a pACYC-based plasmid that codes for the expression of
this enzyme. Competition experiments with CAT substrate
chloramphenicol or known inhibitor fusidic acid confirmed
that L5R5 indeed labeled CAT (Fig. 4C). Both compounds
diminished the signal in a concentration-dependent fashion,
which suggests that L5R5 binds in the same binding pocket.
A recent study demonstrated that CAT also can be labeled with
pentafluoroaryl reactive groups similar to R7,13 but in our case
we only observed good labeling when using sulfonyl fluoride
L5R5. Interestingly, sulfonyl fluoride probes based on L1 and
L4 did not. Furthermore, competition with biotin did not block
labeling of CAT, indicating that the azidolysine is important for
the targeting of CAT. To validate this hypothesis and to target
CAT selectively over BirA, we synthesized benzoyl- and butyryl-
azidolysine ligands L7 and L8. Furthermore, we also prepared
azido-D-serine hydrazide L9 as a chloramphenicol mimic.
Of the newly designed probes, only L7R5 and L8R5 labeled CAT
Fig. 3 Profiling studies in cell lysate of BirA-overexpressing E. coli.
(A) In-gel fluorescence using BODIPY-azide or BODIPY-alkyne as read-out.
The CBB lane is a representative example of the total protein content in the
cell lysate. (B) Western blotting using streptavidin–horseradish peroxidase
as read-out. CBB: Coomassie Brilliant Blue, BCCP: biotin carboxy carrier
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(Fig. 4D and Fig. S15, ESI†). As expected, replacing the biotin for a
benzoyl or butyryl group leads to reduced BirA labeling. Docking of
the probes in the X-ray crystal structure of CAT bound to fusidic
acid (PDB ID: 1Q23) showed that they may adopt a pose in which
the sulfonyl fluoride is in proximity to catalytic histidine residue
193 (Fig. S16, ESI†). Alkylation of this histidine with methyl
4-nitrobenzenesulfonate14 inhibited labeling of CAT, indicating
that this residuemight bemodified by our probes. However, several
of the sulfonyl fluorides that did not label CAT, including L9R5,
adopt a similar pose. While the docking helps to explain the
outcome, its predictive value is limited, once more underpinning
the importance of screening combinations.
In conclusion, we here describe a novel combinatorial approach to
prepare chemical probes. Readily available carbonyl-functionalized
protein labeling reagents can be reacted with a-nucleophiles to form
chemical probes that modify their targets selectively within a mixture
of proteins and cell lysates. The described methodology allows
straightforward screening of the selectivity of ligand-reactive group
combinations using reaction mixtures. The identification of novel
probes for CA-II and three diﬀerent biotin-binding proteins, and the
serendipitous discovery of a probe for CAT underlines the power of
our methodology. Hydrazides are readily prepared from acids or
esters. Therefore, a large number of diﬀerent scaﬀolds can be
converted into suitable ligands for our methodology. As a conse-
quence, our methodology should be applicable towards many diﬀer-
ent protein targets. Thus, combined with the simplified development
of probes and the power of straightforward screening of reactive
groups, we envision that our modular probe synthesis methodology
will considerably simplify chemical probe development.
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